Spectral Medical Inc. EDT
Updated: 10 Aug 2026
No signal published yet
We already track Spectral Medical and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Spectral Medical Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Spectral Medical free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 7, 2026, Spectral reported its second-quarter 2026 financial results and provided a corporate update following the U.S. FDA's formal acceptance of its Premarket Approval application for PMX for substantive review. The submission was supported by positive 12-month follow-up data from the Phase III Tigris trial, which demonstrated sustained survival benefits.
What Firelda Watch includes for Spectral Medical Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Spectral Medical Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Spectral Medical free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more